Take 1 capsule in the morning and evening
taking drugs influencing glucose/lipid metabolism, i.e., antidiabetics, lipid-lowering agents, glucocorticoids, contraceptives, non-steroidal anti-inflammatory drugs (NSAIDs), -blockers
Recent Industry Developments FDA Approval of Oral Wegovy and Orforglipron (Regulatory): On December 22, 2025, the FDA approved the first oral GLP-1 specifically for chronic weight management (the Wegovy pill), which launched in January 2026
Multiple recrystallization cycles are often performed to achieve the high purity levels required for pharmaceutical-grade L-Glutathione Reduced powder
Temperature excursions above 25C cause irreversible structural changes
missing values were replaced by the mean